MELA Sciences, Inc., a developer of technological solutions for melanoma detection, has received CE Marking for the MelaFind lesion imaging system. The device was covered on Medgadget some time ago and is a non invasive imaging tool designed to assist dermatologists in the detection of early melanoma.
The MelaFind system comprises a hand-held detector and a series of image processing algorithms to identify and classify the lesion using the company’s proprietary database of pigmented skin lesions.
From the company website:
The MelaFind hand-held imager, used to capture lesion images, is made up of:
- An illuminator that shines light of 10 different speci?c wavelengths, including near infrared bands
- A lens system composed of 9 elements that creates images of the light scattered back from the lesions
- A photon (light) sensor
MelaFind’s automatic image analysis algorithms include:
- Image calibration to reduce noise and artifacts in the images
- Image quality control to automatically detect problems such as overexposure, underexposure, inappropriate lesion size or too much hair and when appropriate, direct the MelaFind operator to re-image the lesion
- Lesion segmentation to identify portions of the image that belong to the lesion
- Feature extraction to compute parameters characterizing lesions
- Lesion classification to di?erentiate pigmented skin lesions that are positive for melanoma from pigmented skin lesions that are negative for the disease
MELA Sciences plan on launching the MelaFind initially in dermatology clinics in Germany and are currently awaiting feedback from the FDA on a Pre-Market Approval application for the system in the United States.
Press release: MELA Sciences Receives European Union Approval for MelaFind(R)…
